3 Stocks To Watch With New Highs This Month

Stocks opened higher Tuesday, even amid some hard hits from China-based names, as the market looked pull ahead. Earnings season continues to roll on this week as a number of companies report quarterly results.

Leading into the mid morning session, the S&P 500 index is up higher than Monday’s closing level. Hovering in the wings has also been unrest about Turkish currency as well. The knee-jerk reaction from the market has seen a number of stocks plummet during the last 2 trading session. However, with this being the case, a few issuers are starting to see fresh, new highs for August.

GT Biopharma (GTBP) has managed to hit highs of $2.30 this morning after announcing that its Chief Executive Officer, Dr. Raymond W. Urbanski, will present at the upcoming Wedbush PacGrow Healthcare Conference.

Wedbush Securities’ Corporate Access Conferences bring together our institutional clients with leading global companies from a wide-array of sectors. Investors gain access to management teams from prominent public and best-of-breed private companies through intimate small group meetings and corporate presentations. This conference format provides our clients with significant insight and opportunities, while demonstrating our strong commitment to providing premier research and execution services.

GT Biopharma’s OXS-1550 has received much more attention this year as well. This therapy targets two antigens on cancer cells and contains a cytotoxic payload, which increases the probability that it will kill the cancer cells. Initial pre-clinical work performed by Dr. Vallera suggests a much greater effect when OXS-1550 is given in combination with this established oncology drug.

Truett-Hurst, Inc. (THST) has come into the public’s microscope after it announced that it sold its wholesale wine business to Precept Brands LLC. Truett-Hurst’s wholesale wine business consists of the Company’s wholesale bottled wine inventory, brands, supplies and bulk wine inventory used for the Company’s “control label” wine brands and related intellectual property. These wholesale brands are produced under a variety of labels and sold primarily to national retail chains.  The Company will retain its Direct to Consumer business and Dry Creek Valley Estate in Healdsburg, California.

The transaction is expected to result in proceeds of approximately $15.9 million for the Company, net of taxes and transaction-related expenses and fees.

Shares of Truett-Hurst have jumped by as much as 119.6% above Monday’s closing price, during pre market trading on Tuesday.

Today, shares of HyreCar Inc. (HYRE) hit new August highs following an early morning run to $4.10. The company announced that it is expanding its unique car dealer focused “path to ownership” program with car dealerships in six cities throughout the United States, potentially adding upwards of 500 vehicles to the platform. Rideshare drivers are now able to rent and drive-to-own vehicles that are listed on the HyreCar platform by participating dealers.

“The reception to our dealer enabling program has been overwhelming,” said Joe Furnari, Chief Executive Officer of HyreCar Inc. “As a result, we are mobilizing very quickly to meet dealer demand all over the United States. These dealer additions will help us meet the increasing demand for ridesharing-approved vehicles, while also adding additional vehicles to our growing platform.”

MIDAM VENTURES LLC., a Florida Corporation has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). Midam owns zero shares. Midam may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.